Raiffeisen Bank International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.9M Buy
370,130
+63,418
+21% +$14.1M 1.13% 13
2025
Q4
$70.5M Sell
306,712
-4,561
-1% -$1.04M 0.91% 18
2025
Q3
$69.5M Sell
311,273
-9,630
-3% -$1.96M 0.92% 24
2025
Q2
$59.5M Sell
320,903
-18,503
-5% -$3.44M 0.88% 27
2025
Q1
$69.7M Sell
339,406
-14,849
-4% -$2.89M 1.11% 21
2024
Q4
$62.4M Buy
+354,255
New +$65.1M 0.95% 25

Other funds holding ABBV

Raiffeisen Bank International's ABBV Position: Q1 2026 in Review

Raiffeisen Bank International increased its AbbVie (ABBV) stake by 21% in Q1 2026, buying an estimated $14.1M and bringing the position to 370,130 shares worth $78.9M. The position accounts for 1.13% of the portfolio, ranked #13.

Raiffeisen Bank International first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Raiffeisen Bank International held 370,130 shares of AbbVie worth $78.9M as of Q1 2026.
  • Raiffeisen Bank International bought 63,418 AbbVie shares in Q1 2026, an estimated $14.1M.
  • AbbVie made up 1.13% of Raiffeisen Bank International's portfolio in Q1 2026, its #13 holding.
  • Raiffeisen Bank International first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.